Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy
Clinical trial NCT02483871 · WITHDRAWN
Trial details
- NCT number
- NCT02483871
- Sponsor
- Duke University
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2017-05-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.